P53 and Cancer-Associated Sialylated Glycans Are Surrogate Markers of Cancerization of the Bladder Associated with Schistosoma haematobium Infection

PLoS Neglected Tropical Diseases

Volumn 8, Issue 12, 2014, Pages

  Santos, Júlio ^a,b   Fernandes, Elisabete ^a,c   Ferreira, José Alexandre ^a,d   Lima, Luís ^a,e,f   Tavares, Ana ^a   Peixoto, Andreia ^a   Parreira, Beatriz ^a   Correia da Costa, José Manuel ^g,h   Brindley, Paul J ⁱ   Lopes, Carlos ^a,g   Santos, Lúcio L ^a,j,k  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b Luanda   (Angola)

^c Grupo de Investigação em Cancro Digestivo GICD   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

^e Research Department   (Portugal)

^f POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^g UNIVERSITY OF PORTO   (Portugal)

^h NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

ⁱ GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^j UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^k National Cancer Center   (Angola)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; KI 67 ANTIGEN; PROTEIN P53; SIALYL LEWIS X ANTIGEN; SIALYLATED GLYCAN; UNCLASSIFIED DRUG; N ACETYLNEURAMINIC ACID; POLYSACCHARIDE; TP53 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; BLADDER CANCER; BLADDER CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PROTEIN EXPRESSION; SCHISTOSOMIASIS HAEMATOBIA; SCHOOL CHILD; VERY ELDERLY; ANIMAL; BLADDER DISEASE; BLADDER TUMOR; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PARASITOLOGY; PATHOLOGY; SCHISTOSOMA HAEMATOBIUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BIOMARKERS, TUMOR; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; POLYSACCHARIDES; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER DISEASES; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84923089418     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003329     Document Type: Article

References (64)

1. Abdulamir AS, Hafidh RR, Kadhim HS, Abubakar F, (2009) Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors. J Exp Clin Cancer Res 28: 27 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2650688&tool=pmcentrez&rendertype=abstract Accessed 7 November 2013
2. Van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125–139 Available: http://linkinghub.elsevier.com/retrieve/pii/S0001706X03000299 Accessed 8 February 2014
3. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411–425 Available: http://www.ncbi.nlm.nih.gov/pubmed/16790382
4. Hotez PJ, Kamath A, (2009) Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3: e412 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2727001&tool=pmcentrez&rendertype=abstract Accessed 7 February 2014.
5. Cummings R, Nyame A, (1996) Glycobiology of schistosomiasis. FASEB J 10: 838–848 Available: http://www.fasebj.org/content/10/8/838.short Accessed 20 May 2014
6. Shebel HM, Elsayes KM, Abou El, Atta HM, Elguindy YM, El-Diasty TA, , (n.d.) Genitourinary schistosomiasis: life cycle and radiologic-pathologic findings. Radiographics 32: 1031–1046 Available: http://www.ncbi.nlm.nih.gov/pubmed/22786992 Accessed 10 May 2014
7. Fu C-L, Odegaard JI, Herbert DR, Hsieh MH, (2012) A novel mouse model of Schistosoma haematobium egg-induced immunopathology. PLoS Pathog 8: e1002605 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3315496&tool=pmcentrez&rendertype=abstract Accessed 30 April 2014
8. Botelho MC, Oliveira P a, Lopes C, Correia da Costa JM, Machado JC, (2011) Urothelial dysplasia and inflammation induced by Schistosoma haematobium total antigen instillation in mice normal urothelium. Urol Oncol 29: 809–814 Available: http://www.ncbi.nlm.nih.gov/pubmed/19945304 Accessed 5 November 2013
9. Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S, et al. (2008) Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer 123: 601–608 Available: http://www.ncbi.nlm.nih.gov/pubmed/18478569 Accessed 10 May 2014
10. Swierczynski SL, Epstein JI, (2002) Prognostic significance of atypical papillary urothelial hyperplasia. Hum Pathol 33: 512–517 Available: http://www.ncbi.nlm.nih.gov/pubmed/12094376 Accessed 10 May 2014
11. IARC (2012) A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100 B: 1–441.
12. Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif HH, et al. (1998) Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 77: 1186–1189 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2150141&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
13. Zheng Y-L, Amr S, Saleh DA, Dash C, Ezzat S, et al. (2012) Urinary bladder cancer risk factors in Egypt: a multicenter case-control study. Cancer Epidemiol Biomarkers Prev 21: 537–546 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3297723&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
14. Salem S, Mitchell RE, El-Alim El-Dorey A, Smith JA, Barocas DA, (2011) Successful control of schistosomiasis and the changing epidemiology of bladder cancer in Egypt. BJU Int 107: 206–211 Available: http://www.ncbi.nlm.nih.gov/pubmed/21208365 Accessed 10 May 2014
15. Rambau PF, Chalya PL, Jackson K, (2013) Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients. Infect Agent Cancer 8: 19 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3665673&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
16. Herrera LA, Benítez-Bribiesca L, Mohar A, Ostrosky-Wegman P, (2005) Role of infectious diseases in human carcinogenesis. Environ Mol Mutagen 45: 284–303 Available: http://www.ncbi.nlm.nih.gov/pubmed/15744742 Accessed 10 May 2014
17. Hodder SL, Mahmoud AA, Sorenson K, Weinert DM, Stein RL, et al. (2000) Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg 63: 133–138 Available: http://www.ncbi.nlm.nih.gov/pubmed/11388504 Accessed 10 May 2014
18. Leutscher PDC, Ramarokoto C-E, Hoffmann S, Jensen JS, Ramaniraka V, et al. (2008) Coexistence of urogenital schistosomiasis and sexually transmitted infection in women and men living in an area where Schistosoma haematobium is endemic. Clin Infect Dis 47: 775–782 Available: http://www.ncbi.nlm.nih.gov/pubmed/18680415 Accessed 10 May 2014
19. Botelho M, Oliveira P, Gomes J, Gartner F, Lopes C, et al. (2009) Tumourigenic effect of Schistosoma haematobium total antigen in mammalian cells. Int J Exp Pathol 90: 448–453 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2741155&tool=pmcentrez&rendertype=abstract Accessed 5 May 2014
20. Botelho M, Ferreira AC, Oliveira MJ, Domingues A, Machado JC, et al. (2009) Schistosoma haematobium total antigen induces increased proliferation, migration and invasion, and decreases apoptosis of normal epithelial cells. Int J Parasitol 39: 1083–1091 Available: http://www.ncbi.nlm.nih.gov/pubmed/19285502 Accessed 10 May 2014
21. Zhong X, Isharwal S, Naples JM, Shiff C, Veltri RW, et al. (2013) Hypermethylation of genes detected in urine from Ghanaian adults with bladder pathology associated with Schistosoma haematobium infection. PLoS One 8: e59089 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3601097&tool=pmcentrez&rendertype=abstract Accessed 11 November 2013
22. Network TCGAR, (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507: 315–322 Available: http://www.ncbi.nlm.nih.gov/pubmed/24476821 Accessed 29 April 2014
23. Hemal AK, Khaitan A, Dinda AK, Gupta NP, Seth A, et al. (2003) Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy. Urol Int 70: 42–46 Available: http://www.ncbi.nlm.nih.gov/pubmed/12566814 Accessed 10 May 2014
24. Vardar E, Gunlusoy B, Minareci S, Postaci H, Ayder AR, (2006) Evaluation of p53 nuclear accumulation in low- and high-grade (WHO/ISUP classification) transitional papillary carcinomas of the bladder for tumor recurrence and progression. Urol Int 77: 27–33 Available: http://www.ncbi.nlm.nih.gov/pubmed/16825812 Accessed 10 May 2014
25. Badr KM, Nolen JDL, Derose PB, Cohen C, (2004) Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1). Hum Pathol 35: 184–189 Available: http://www.ncbi.nlm.nih.gov/pubmed/14991535 Accessed 10 May 2014
26. Santos L, Amaro T, Costa C, Pereira S, Bento MJ, et al. (2003) Ki-67 index enhances the prognostic accuracy of the urothelial superficial bladder carcinoma risk group classification. Int J Cancer 105: 267–272 Available: http://www.ncbi.nlm.nih.gov/pubmed/12673690 Accessed 10 May 2014
27. Margulis V, Lotan Y, Karakiewicz PI, Fradet Y, Ashfaq R, et al. (2009) Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer. J Natl Cancer Inst 101: 114–119 Available: http://www.ncbi.nlm.nih.gov/pubmed/19141773 Accessed 10 May 2014
28. Ding W, Gou Y, Sun C, Xia G, Wang H, et al. (2014) Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC. Urol Oncol 32: 42.e13–9 Available: http://www.ncbi.nlm.nih.gov/pubmed/24360660 Accessed 10 May 2014
29. Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M, (2012) Mechanisms of cancer-associated glycosylation changes. Front Biosci Landmark Ed 17: 670–699 Available: http://www.ncbi.nlm.nih.gov/pubmed/22201768 Accessed 10 May 2014
30. Lima L, Severino PF, Silva M, Miranda A, Tavares A, et al. (2013) Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy. Br J Cancer 109: 2106–2114 Available: http://www.ncbi.nlm.nih.gov/pubmed/24064971 Accessed 29 April 2014
31. Ferreira JA, Videira P a, Lima L, Pereira S, Silva M, et al. (2013) Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours. Mol Oncol 7: 719–731 Available: http://www.ncbi.nlm.nih.gov/pubmed/23567325
32. Nagao K, Itoh Y, Fujita K, Fujime M, (2007) Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes. Int J Urol 14: 795–799 Available: http://www.ncbi.nlm.nih.gov/pubmed/17760744 Accessed 10 May 2014
33. Pal K, Roy S, Mondal SA, Chatterjee U, Tiwari P, et al. (2011) Urinary level of CA19-9 as a tumor marker in urothelial carcinoma of the bladder. Urol J 8: 203–208 Available: http://www.ncbi.nlm.nih.gov/pubmed/21910099 Accessed 10 May 2014
34. Hegele A, Mecklenburg V, Varga Z, Olbert P, Hofmann R, et al. (2010) CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings. Anticancer Res 30: 5195–5200 Available: http://www.ncbi.nlm.nih.gov/pubmed/21187512 Accessed 10 May 2014
35. Numahata K, Satoh M, Handa K, Saito S, Ohyama C, et al. (2002) Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer 94: 673–685 Available: http://www.ncbi.nlm.nih.gov/pubmed/11857299 Accessed 10 May 2014
36. Kajiwara H, Yasuda M, Kumaki N, Shibayama T, Osamura Y, (2005) Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder. Tokai J Exp Clin Med 30: 177–182 Available: http://www.ncbi.nlm.nih.gov/pubmed/16285609 Accessed 10 May 2014
37. Anastasi E, Granato T, Falzarano R, Storelli P, Ticino A, et al. (2013) The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer. J Ovarian Res 6: 44 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3701500&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
38. Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y, (2014) Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17: 26–33 Available: http://www.ncbi.nlm.nih.gov/pubmed/23572188 Accessed 10 May 2014
39. Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BWG, et al. (2013) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 64: 639–653 Available: http://www.ncbi.nlm.nih.gov/pubmed/23827737 Accessed 12 May 2014
40. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, et al. (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59: 997–1008 Available: http://www.ncbi.nlm.nih.gov/pubmed/21458150 Accessed 29 April 2014
41. Weintraub M, Khaled H, Zekri A, Bahnasi A, Eissa S, et al. (1995) P53 mutations in egyptian bladder-cancer. Int J Oncol 7: 1269–1274 Available: http://www.ncbi.nlm.nih.gov/pubmed/21552959 Accessed 10 May 2014
42. Botelho MC, Machado JC, Brindley PJ, Correia da Costa JM, (2011) Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer. Virulence 2: 267–279 Available: http://www.landesbioscience.com/journals/virulence/article/16734/ Accessed 8 May 2014
43. Shental-Bechor D, Levy Y, (2009) Folding of glycoproteins: toward understanding the biophysics of the glycosylation code. Curr Opin Struct Biol 19: 524–533 Available: http://www.ncbi.nlm.nih.gov/pubmed/19647993 Accessed 10 May 2014
44. Ohtsubo K, Marth JD, (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126: 855–867 Available: http://www.ncbi.nlm.nih.gov/pubmed/16959566 Accessed 29 April 2014
45. Haltiwanger RS, Lowe JB, (2004) Role of glycosylation in development. Annu Rev Biochem 73: 491–537 Available: http://www.ncbi.nlm.nih.gov/pubmed/15189151 Accessed 8 May 2014
46. Carrascal MA, Severino PF, Guadalupe Cabral M, Silva M, Ferreira JA, et al. (2014) Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells. Mol Oncol 8: 753–765 Available: http://www.ncbi.nlm.nih.gov/pubmed/24656965 Accessed 10 May 2014
47. Gakhar G, Navarro VN, Jurish M, Lee GY, Tagawa ST, et al. (2013) Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow. PLoS One 8: e85143 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3874033&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
48. Komatsu H, Mizuguchi S, Izumi N, Chung K, Hanada S, et al. (2013) Sialyl Lewis X as a predictor of skip N2 metastasis in clinical stage IA non-small cell lung cancer. World J Surg Oncol 11: 309 Available: http://www.ncbi.nlm.nih.gov/pubmed/24313932 Accessed 10 May 2014
49. Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, et al. (2011) Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers. Cancer Res 71: 7683–7693 Available: http://www.ncbi.nlm.nih.gov/pubmed/22025563 Accessed 10 May 2014
50. Kannagi R, (2007) Carbohydrate antigen sialyl Lewis a—its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 30: 189–209 Available: http://www.ncbi.nlm.nih.gov/pubmed/17760270
51. Neves AA, Stöckmann H, Harmston RR, Pryor HJ, Alam IS, et al. (2011) Imaging sialylated tumor cell glycans in vivo. FASEB J 25: 2528–2537 Available: http://www.ncbi.nlm.nih.gov/pubmed/21493886 Accessed 10 May 2014
52. Neves AA, Stöckmann H, Wainman YA, Kuo JC-H, Fawcett S, et al. (2013) Imaging cell surface glycosylation in vivo using “double click” chemistry. Bioconjug Chem 24: 934–941 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3687584&tool=pmcentrez&rendertype=abstract Accessed 1 May 2014
53. Reis C a, Osorio H, Silva L, Gomes C, David L, (2010) Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 63: 322–329 Available: http://www.ncbi.nlm.nih.gov/pubmed/20354203 Accessed 17 September 2013
54. Casaravilla C, Freire T, Malgor R, Medeiros A, Osinaga E, et al. (2003) Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase activity. J Parasitol 89: 709–714 Available: http://www.ncbi.nlm.nih.gov/pubmed/14533679 Accessed 10 May 2014
55. Gowda DC, Davidson EA, (1999) Protein glycosylation in the malaria parasite. Parasitol Today 15: 147–152 Available: http://www.ncbi.nlm.nih.gov/pubmed/10322336 Accessed 10 May 2014
56. Barthel SR, Gavino JD, Descheny L, Dimitroff CJ, (2007) Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets 11: 1473–1491 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2559865&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
57. Pan LH, Yamauchi K, Sawai T, Nakadate T, Kojima Y, et al. (2000) Inhibition of binding of E- and P-selectin to sialyl-Lewis X molecule suppresses the inflammatory response in hypersensitivity pneumonitis in mice. Am J Respir Crit Care Med 161: 1689–1697 Available: http://www.ncbi.nlm.nih.gov/pubmed/10806176 Accessed 10 May 2014
58. Brunk DK, Goetz DJ, Hammer DA, (1996) Sialyl Lewis(x)/E-selectin-mediated rolling in a cell-free system. Biophys J 71: 2902–2907 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1233776&tool=pmcentrez&rendertype=abstract Accessed 30 April 2014
59. Komatsu T, Nagano K, Sugiura S, Hagiwara M, Tanigawa N, et al. (2012) E-selectin mediates Porphyromonas gingivalis adherence to human endothelial cells. Infect Immun 80: 2570–2576 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3416463&tool=pmcentrez&rendertype=abstract Accessed 29 April 2014
60. St Hill CA, (2011) Interactions between endothelial selectins and cancer cells regulate metastasis. Front Biosci Landmark Ed 16: 3233–3251 Available: http://www.ncbi.nlm.nih.gov/pubmed/21622232 Accessed 10 May 2014
61. Young ND, Jex AR, Li B, Liu S, Yang L, et al. (2012) Whole-genome sequence of Schistosoma haematobium. Nat Genet 44: 221–225 Available: http://www.ncbi.nlm.nih.gov/pubmed/22246508 Accessed 29 April 2014
62. Kawarada Y, Ishikura H, Kishimoto T, Kato H, Yano T, et al. (2000) The role of sialylated Lewis antigens on hematogenous metastases of human pancreas carcinoma cell lines in vivo. Pathol Res Pract 196: 259–263 Available: http://www.ncbi.nlm.nih.gov/pubmed/10782470 Accessed 10 May 2014
63. Yoshino TP, Wu X-J, Liu H, Gonzalez LA, Deelder AM, et al. (2012) Glycotope sharing between snail hemolymph and larval schistosomes: larval transformation products alter shared glycan patterns of plasma proteins. PLoS Negl Trop Dis 6: e1569 Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3308936&tool=pmcentrez&rendertype=abstract Accessed 10 May 2014
64. Mendes TAO, Lobo FP, Rodrigues TS, Rodrigues-Luiz GF, daRocha WD, et al. (2013) Repeat-enriched proteins are related to host cell invasion and immune evasion in parasitic protozoa. Mol Biol Evol 30: 951–963 Available: http://www.ncbi.nlm.nih.gov/pubmed/23303306 Accessed 1 May 2014